Top 5 Takeaways Surge in Pediatric COVID-19 Cases: During the 2021–22 school year, New York reported a total of 702,686 COVID-19 cases among children aged 5–17, with a significant increase
Tag: Infectious Disease
Top 5 Takeaways Enhanced Risk for Persons with HIV: Persons with advanced HIV infection, especially those not virologically suppressed with antiretroviral therapy (ART), may face increased risk for severe monkeypox
Top 5 Takeaways Significant Reporting Disparity: During the study period, 10.7 million self-test results were reported compared to 361.9 million laboratory-based and point-of-care test results, highlighting a vast underreporting of
Top 5 Takeaways Low Treatment Rates Across Age and Insurance Types: Direct-acting antiviral (DAA) treatment rates for hepatitis C are notably low, especially among young adults aged 18–29 years and
Top 5 Takeaways Disproportionate Impact on Specific Populations: 99% of monkeypox cases occurred in men, with 94% reporting male-to-male sexual or close intimate contact. Racial and ethnic minority groups, particularly
Top 5 Takeaways Strategic Public Health Recommendations: Emphasis on vaccination and therapeutics to prevent severe illness, complemented by nonpharmaceutical interventions for exposure risk reduction and focus on high-risk individuals. Vaccination
Top 5 Takeaways Higher Incidence and Mortality in Public Transportation: Public transportation industries in California had 1.5 times the cumulative COVID-19 outbreak incidence and mortality rates compared to all industries,
Top 5 Takeaways Confirmed Case of Poliomyelitis in Unvaccinated Adult: In June 2022, an unvaccinated adult in New York developed paralytic poliomyelitis, marking a rare occurrence in the U.S., where
Top 5 Takeaways Significant progress in measles vaccination coverage: From 2003 to 2020, estimated coverage for the first and second doses of measles-containing vaccine (MCV1 and MCV2) in the South-East
Top 5 Takeaways Similar Adverse Reaction Frequencies: Children aged 5–11 years reported local and systemic reactions to the Pfizer-BioNTech COVID-19 vaccine booster dose with similar frequency as after the second